News

Find out all the latest news and information on DHDDS here

connections-2099068_640

Cure DHDDS Virtual Conference: Summary Report

Click on the link below to see a summary of the virtual conference hosted by Costello Medical. We very much hope that by bringing the scientific community together we can expedite research into these ultra rare mutations.
thumbnail_FB34D438B19C44E199532307C2667184

Mel Dixon to speak at Festival of Genomics in 2024

We are pleased to announce that our founder Mel Dixon will be speaking at the Festival of Genomics on 24th January 2024 about her race against time to find a treatment for the ultra rare DHDDS mutations.
download

Medical Podcast features DHDDS parents & advocates from Portugal.

The latest House of Pod: A Medical Podcast features our wonderful fellow DHDDS parents and advocates John and Zoe from Portugal. The Man discussing with Dr. Stan Crooke of the N-Lorem Foundation and Dr. Kaveh Honda MD, the challenges of having a child with a nano rare disease. Please listen if you can. This podcast not only takes you on the heartfelt journey of having a child with an ultra rare disease, but also looks at their hopes for an ASO therapy with N-Lorem and highlights the importance of genomics in medicine.  
home-office-5231389_1280

First DHDDS Virtual Conference - September 2023

Cure DHDDS is proud to announce its first virtual conference on September 21st 2023. The event will be hosted by Costello Medical and gives the opportunity for leading international scientists to come together to discuss current and future research.

Cure DHDDS features in SW Londoner  

Cure DHDDS charity features in SW Londoner discussing its fundraising and research aims and achievements to date.
American Flag 2

Launch of Cure DHDDS USA 

Fellow DHDDS parents Zoe Manville and John Gourley are to launch Cure DHDDS USA. We are very excited by the launch of Cure DHDDS USA - website: curedhddsusa.org

We have been working with Zoe and John for some months now developing research opportunities and building on our network of scientific experts. Together we are stronger and can work faster to find a treatment for these ultra rare mutations.

doctor-gdc054a375_1280

New contract signed for research in Montreal 

Cure DHDDS have just signed a contract for research into models at CHU Sainte Justine university Montreal.
download

Perlara drug repurposing contract signed 

Cure DHDDS and Cure DHDDS USA have recently signed a contract for drug repurposing screen with Perlara.
download (1)

Cure DHDDS Raise awareness on American TV

Cure DHDDS have been raising awareness of the ultra rare disease on both ABC News and Good Morning America this month.

Cure DHDDS on ITV London Tonight 

Uncle and charity Patron, Joe Absolom appeared on London Tonight to raise awareness of the Cure DHDDS Charity and the ultra rare condition.
ch4

Cure DHDDS Patron on Channel 4

Cure DHDDS Patron and uncle to two DHDDS siblings Joe Absolom speaks out on Steph’s Packed Lunch on Channel 4 about the challenges faced by individuals with DHDDS mutations.

Mel Dixon speaks at Beacons Conference 2023

Click the play button to hear Cure DHDDS founder Mel Dixon speaking at Beacons rare disease conference in June 2023.
Video Still

Cure DHDDS Proud to reveal new short film

Cure DHDDS is proud to reveal its short film on DHDDS symptoms which the charity hopes will help to raise awareness and understanding of the condition.

Produced by: Cine Schools

biotin

Biotin as a new therapeutic approach?

Reduced Biotinidase Activity in Patients with congenital disorders of glycosylation (CGD)

Publication: Molecular Genetics and Metabolism

dna-g8f2d15a1e_640

EpiSignature Study into DHDDS Gene Mutation

EpiSignature is a study of genomic DNA methylation patterns (beyond the coding sequences) to differentiate patients with similar or different phenotypes and genetic changes at the DNA coding level.

Genetic changes in the DHDDS gene have been found in some cases to be associated with a progressive course, while in other cases a static course. EpiSignature tries to determine whether there is any significant difference in methylation pattern that could account for such difference, thus potentially providing some insight for progression and prognosis.

Charity founders in South East Genomics article

Cure DHDDS founders Mel and Charlie Dixon feature in South East Genomics article discussing the struggles and opportunities that come with an ultra rare genetic diagnosis.